Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ
Analgesics
/ chemical synthesis
Animals
Benzazepines
/ chemical synthesis
Dose-Response Relationship, Drug
Excitatory Amino Acid Antagonists
/ chemical synthesis
Female
Humans
Hyperalgesia
/ drug therapy
Ligands
Mice
Microsomes, Liver
/ metabolism
Molecular Structure
Piperidines
/ therapeutic use
Rats
Receptors, N-Methyl-D-Aspartate
/ antagonists & inhibitors
Receptors, sigma
/ antagonists & inhibitors
Stereoisomerism
Structure-Activity Relationship
Sigma-1 Receptor
Antiallodynic activity
Fluorinated side chain
GluN2B subunit selective NMDA receptor antagonist
NMDA receptor
PET
Receptor selectivity
Structure activity relationships
Tetrahydro-3-benzazepines
σ(1) receptor selectivity
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
01 Sep 2019
01 Sep 2019
Historique:
received:
22
03
2019
revised:
23
04
2019
accepted:
12
05
2019
pubmed:
28
5
2019
medline:
26
7
2019
entrez:
27
5
2019
Statut:
ppublish
Résumé
The class of tetrahydro-1H-3-benzazepines was systematically modified in 1-, 3- and 7-position. In particular, a F-atom was introduced in β- or γ-position of the 4-phenylbutyl side chain in 3-position. Ligands with the F-atom in γ-position possess higher GluN2B affinity than analogs bearing the F-atom in β-position. This effect was attributed to the reduced basicity of β-fluoro amines. 3-Benzazepines with a benzylic OH moiety show moderate GluN2B affinity, but considerable selectivity over the σ
Identifiants
pubmed: 31129453
pii: S0223-5234(19)30444-1
doi: 10.1016/j.ejmech.2019.05.034
pii:
doi:
Substances chimiques
Analgesics
0
Benzazepines
0
Excitatory Amino Acid Antagonists
0
Ligands
0
NR2B NMDA receptor
0
Piperidines
0
Receptors, N-Methyl-D-Aspartate
0
Receptors, sigma
0
ifenprodil
R8OE3P6O5S
Types de publication
Journal Article
Langues
eng
Pagination
47-62Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.